Invasive approaches such as PCI and CABG offer no benefits over conservative medical therapy for patients with stable coronary disease who have moderate or severe ischaemia, according to the long-awaited results of the ISCHEMIA study. Published in the NEJM, the findings from the study that enrolled more than 5000 patients showed no difference in the ...
ISCHEMIA jury is in: don’t rush to invasive approaches in stable CAD
By Michael Woodhead
24 Jun 2020